GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
1.780
+0.030 (1.71%)
At close: Oct 29, 2024, 4:00 PM
1.840
+0.060 (3.37%)
After-hours: Oct 29, 2024, 7:33 PM EDT
Company Description
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States.
It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
GlucoTrack, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Paul Goode |
Contact Details
Address: 301 Route 17 North, Suite 800 Rutherford, New Jersey 07070 United States | |
| Phone | 201 842 7715 |
| Website | glucotrack.com |
Stock Details
| Ticker Symbol | GCTK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506983 |
| CUSIP Number | 45824Q507 |
| ISIN Number | US45824Q5071 |
| Employer ID | 98-0668934 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul V. Goode Ph.D. | Chief Executive Officer, President and Director |
| Mark Tapsak Ph.D. | Vice President of Technology |
| Drinda Benjamin | Vice President of Marketing |
| James P. Thrower Ph.D. | Vice President of Engineering |
| Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board |
| David Malka BA | Co-Founder |
| James S. Cardwell | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 24, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Oct 22, 2024 | 8-K | Current Report |
| Oct 3, 2024 | EFFECT | Notice of Effectiveness |
| Oct 1, 2024 | 8-K | Current Report |
| Sep 30, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Sep 26, 2024 | 8-K | Current Report |
| Sep 23, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Sep 16, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Sep 10, 2024 | 8-K | Current Report |
| Sep 10, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |